Evidence map›Paper›PMID 34470501›Full record

ArticleCirculation. Cardiovascular interventions2021

Long-Term Results up to 12 Months After Catheter-Based Alcohol-Mediated Renal Denervation for Treatment of Resistant Hypertension.

Felix Mahfoud, Horst Sievert, Stefan Bertog, Lucas Lauder, Sebastian Ewen, Jean-Philippe Lengelé, Wojciech Wojakowski, Roland Schmieder, Markus van der Giet, Michael A Weber and 5 more

Open access · hybridAbstract read
In one paragraph

Article in Circulation. Cardiovascular interventions, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 15 citations in OpenAlex.

  1. Alcohol-mediated renal denervation in patients with hypertension in the absence of antihypertensive medications.EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology · 2023
    Trial
  2. Review
  3. Renal denervation in the management of hypertension.EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology · 2024
    Article
  4. Review
  5. Hypertension research from Japan: advancing the field of renal denervation.Hypertension research : official journal of the Japanese Society of Hypertension · 2022
    Article
  6. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 11 institutions in 7 countries.

Felix MahfoudDepartment of Internal Medicine III, Cardiology, Angiology, Intensive Care Medicine, Saarland University Medical Center, Homburg, Germany (F.M., L.L., S.E.).ORCID 0000-0002-4425-549X
Horst SievertCardioVascular Center Frankfurt, Germany; Anglia Ruskin University, Chelmsford, United Kingdom; University California San Francisco UCSF; and Yunnan Hospital Fuwai, Kunming, China (H.S.).
Stefan BertogCardioVascular Center Frankfurt, Germany (S.B.).
Lucas LauderDepartment of Internal Medicine III, Cardiology, Angiology, Intensive Care Medicine, Saarland University Medical Center, Homburg, Germany (F.M., L.L., S.E.).ORCID 0000-0003-1434-9556
Sebastian EwenDepartment of Internal Medicine III, Cardiology, Angiology, Intensive Care Medicine, Saarland University Medical Center, Homburg, Germany (F.M., L.L., S.E.).
Jean-Philippe LengeléDivision of Cardiology, Department of Cardiovascular Diseases, Cliniques Universitaires Saint-Luc and Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium (J.-P.L., A.P.).ORCID 0000-0002-0134-1769
Wojciech WojakowskiDepartment of Cardiology and Structural Heart Diseases, Medical University of Silesia, Katowice, Poland (W.W.).
Roland SchmiederUniversity Hospital Erlangen, Friedrich-Alexander University Erlangen, Germany (R.S.).ORCID 0000-0003-2356-5883
Markus van der GietDepartment of Nephrology and Intensive Care Medicine, Charité - Universitätsmedizin Berlin, Germany (M.v.d.G.).
Michael A WeberDivision of Cardiovascular Medicine, SUNY Downstate Medical Center, Brooklyn, NY (M.A.W.).ORCID 0000-0002-8504-0831
David E KandzariPiedmont Heart Institute, Atlanta, GA (D.E.K.).
Helen PariseIndependent statistician, Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT (H.P.).ORCID 0000-0001-7761-4973
Tim A FischellAblative Solutions, Inc, San Jose (T.A.F.).
Atul PathakDivision of Cardiology, Department of Cardiovascular Diseases, Cliniques Universitaires Saint-Luc and Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium (J.-P.L., A.P.).
Saarland University · DECardiovascular Center Frankfurt · DECliniques Universitaires Saint-Luc · BEa.i. solutions (United States) · USCentre Alexandre Koyré · FRCharité - Universitätsmedizin Berlin · DEFriedrich-Alexander-Universität Erlangen-Nürnberg · DEMedical University of Silesia · PLPiedmont Atlanta Hospital · USSUNY Downstate Health Sciences University · USYale University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[Figure: see text].

Indexed as

Catheter AblationHypertensionAntihypertensive AgentsBlood PressureCathetersDenervationHumansKidneyRenal ArterySympathectomyTreatment OutcomeAntihypertensive Agentsalcoholdenervationhypertensionrenal artery

Identifiers

PMID34470501
PMCPMC8452324
OpenAlexW3197092992

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.